Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/EJE-08-0289
European Journal of Endocrinology, Vol 159, Issue 3, 197-202
Copyright © 2008 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
EJE-08-0289v1
159/3/197    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Mueller, A.
Right arrow Articles by Gooren, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mueller, A.
Right arrow Articles by Gooren, L.
REVIEW

Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones

Andreas Mueller and Louis Gooren1

Department of Obstetrics and GynecologyErlangen University Hospital, Universitaetsstr. 21-23, D-91054 Erlangen, Germany1 Department of EndocrinologyVU University Medical Center, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands

(Correspondence should be addressed to L Gooren; Email: louisjgooren{at}gmail.com)

Objective: To assess the risk of development of hormone-related tumors in transsexuals receiving treatment with cross-sex hormones.

Design: Description of cases of transsexuals who have developed a hormone-related malignancy observed in their own clinic or reported in the literature. Recommendations for early diagnosis and prevention are presented.

Methods: Review of the literature in PubMed.

Results: In male-to-female transsexuals receiving estrogen administration, lactotroph adenomas, breast cancer, and prostate cancer have been reported. In female-to-male transsexuals receiving treatment with testosterone, a single case of breast carcinoma and several cases of ovarian cancer have been reported. So far endometrial cancer has not been encountered though it remains a potential malignant development.

Conclusions: There are so far only a few cases of hormone-related cancer in transsexuals. There may be an underreporting. The probability of a hormone-related tumor increases with the duration of exposure to cross-sex hormones and the aging of the population of transsexuals.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 European Society of Endocrinology.